
Aug 25, 2025, 15:59
Cancer Research Institute Highlights Its Role in Immune-Based Cancer Breakthroughs
Cancer Research Institute (CRI) shared a post on LinkedIn:
“Cancer immunotherapy was built, brick by brick, by pioneers who believed the immune system could conquer cancer, when few others did. For more than 70 years, the Cancer Research Institute has been at the center of this story, funding breakthrough discoveries, backing bold scientists, and keeping alive the idea that immune-based treatments could transform cancer care.
From early experiments, to today’s standard-of-care therapies, join CRI in tracing the long road of discovery, and understand CRI’s key role in making these developments possible.”
More posts featuring Cancer Research Institute (CRI) on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 25, 2025, 15:59
Aug 25, 2025, 15:59
Aug 25, 2025, 15:56
Aug 25, 2025, 15:48